In re Sanofi-Aventis Securities Litigation

Case # 07-cv-10279
Case Name In re Sanofi-Aventis Securities Litigation
Jurisdiction US District Court for S.D. NY

Plaintiffs allege that Defendants failed to disclose potentially troubling side-effects of the new weight loss drug, rimonabant, that they were developing.  Through their selective information disclosures, Defendants were able to mislead securities-holders into believing that a potential corporate windfall was imminent.

Final Approval Date 01/22/2014
  1. Final Approval granted.
  2. The Court found that Objector Brown had not established his standing to object.  It also considered the merits of his objection and found it to be without merit.
  3. Objector Brown (through Attorneys Turkish and Palmer) appealed the Final Approval.
  4. The Brown Appeal was dismissed for failure to pay the filing fee.
Dismissal of Last Appeal 04/18/2014
Attachments Docket Report.pdf
First Amended Complaint.pdf
Preliminary Approval.pdf
Plaintiffs' Response to Objections.pdf
Final Approval.pdf
Added to Index
Last Updated

Objection of Jeff M. Brown

Objectors Jeff M. Brown
Signers Forrest S. Turkish
Attorneys Forrest S. Turkish
Joseph Darrell Palmer
  1. Insufficient information was made available for class members to analyze the settlement or the fee request.
  2. Attorneys' fees are excessive and improperly calculated.
  3. Settlement does not fully compensate class members for their losses.

NOTE: Appeal was dismissed for failure to pay the filing fee.

NOTE: Joseph Darrell Palmer filed his appearance on the appeal.

Attachments Objection of Jeff Brown.pdf
Appeal of Objector Brown.pdf
Palmer Appearance for Objector-Appellant Brown.pdf
Dismissal of Brown Appeal.pdf
Brown Appeal Docket.pdf
Added to Index
Last Updated